Such an honour to have presented our research project, our NICSO project to #mascc#MASCC22#toronto@CancerCareMASCC
Terrific experience. Awesome collagueas to confront with. I couldn't but be deeply #honoured
NEWS FROM ESMO 2021
after radical surgery atezolizumab treatment improved DFS compared with best supportive care in patients in the stage II–IIIA population whose tumours expressed PD-L1 on 1% or more of tumour cells (HR 0·66)
#ESMO2021#atezo#LCSM
https://t.co/DRTte5z6M5
Spirituality and spiritual needs are a main issue in clinical oncology, but too often underestimated.
This is one of the works I am most proud of having the chance to take part in.
#spirituality#oncology#patients#ESMOOpen
https://t.co/eikh8mCR2i
EGFr patients progressing on osimertinib were often candidate to chemo. Very soon a new chemo-free option might be available.
#amivantamab#lazertinib#nsclc#egfr#asco2021#LCSM
https://t.co/YHjpszusIu
My first paper ever.
Procalcitonin is important to be analysed in cancer patients with fever. Use it!
#procalcitonin#Cancer#fever#CancerResearch
https://t.co/6h2Skqe9oT